Affiliation:
1. Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA
Abstract
As a major human pathogen, RSV affects 3.4 million children worldwide annually. However, no effective antivirals or vaccines are available. An in-depth mechanistic understanding of the RSV RNA synthesis machinery remains a high priority among the NNS RNA viruses. There is a strong public health need for research on this virus, due to major fundamental gaps in our understanding of NNS RNA virus replication. As the key enzyme executing transcription and replication of the virus, the RSV RdRP is a logical target for novel antiviral drugs. Therefore, exploring the primer-dependent RNA elongation extends our mechanistic understanding of the RSV RNA synthesis. Further fine mapping of the promoter sequence paves the way to better understand the function and structure of the RSV polymerase.
Funder
HHS | NIH | National Institute of General Medical Sciences
Emory University | School of Medicine, Emory University
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference64 articles.
1. Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease
2. Collins PL, Karron RA. 2013. Respiratory syncytial virus and metapneumovirus, p 1087–1118. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 6th ed. vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
4. Progress toward a Respiratory Syncytial Virus Vaccine
5. Respiratory syncytial virus: prospects for new and emerging therapeutics
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献